APA (7th ed.) Citation

Schwotzer, N., Paganetti, G., Barchi, M., Perrottet, N., Aubert, V., Sadallah, S., . . . Pascual, M. (2020). Upfront use of eculizumab to treat early acute antibody‐mediated rejection after kidney allotransplantation and relevance for xenotransplantation. Xenotransplantation, 27(4), 1. https://doi.org/10.1111/xen.12630

Chicago Style (17th ed.) Citation

Schwotzer, Nora, et al. "Upfront Use of Eculizumab to Treat Early Acute Antibody‐mediated Rejection After Kidney Allotransplantation and Relevance for Xenotransplantation." Xenotransplantation 27, no. 4 (2020): 1. https://doi.org/10.1111/xen.12630.

MLA (9th ed.) Citation

Schwotzer, Nora, et al. "Upfront Use of Eculizumab to Treat Early Acute Antibody‐mediated Rejection After Kidney Allotransplantation and Relevance for Xenotransplantation." Xenotransplantation, vol. 27, no. 4, 2020, p. 1, https://doi.org/10.1111/xen.12630.